PRF Technologies PRFX
NASDAQ PRFX
$0.99 -0.02 (-1.54%)
As of: Aug 20, 2026 · 3:59 PM EDT

PRF Technologies (PRFX) Net Income towards Common Stockholders (2020 - 2024)

PRF Technologies' (PRFX) quarterly Net Income towards Common Stockholders came in at -$7.6 million in Q2 2024, down 204.12% YoY from $7.3 million in Q3 2023, and down 30.63% on a QoQ basis from -$5.8 million in Q1 2024.

PRF Technologies (PRFX) Net Income towards Common Stockholders (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$7.6 million in Q2 2024.

  • Quarterly Net Income towards Common Stockholders fell 204.12% year-over-year to -$7.6 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$7.6 million (up 68.54% YoY) and the FY2025 annual result came in at -$5.0 million, up 66.16% from the prior year.
  • Net Income towards Common Stockholders declined to -$7.6 million in Q2 2024, from -$5.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$700000.0 in Q3 2020 to a low of -$10.7 million in Q4 2023.
  • A 5-year average of -$3.7 million and a median of -$2.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 31.46% — and 2024, when it plunged 204.12%.
  • Tracing PRFX's Net Income towards Common Stockholders over 5 years: stood at -$4.2 million in 2020, then plunged by 65.42% to -$6.9 million in 2021, then declined by 28.75% to -$8.9 million in 2022, then dropped by 21.01% to -$10.7 million in 2023, then climbed by 29.24% to -$7.6 million in 2024.
  • The last three Net Income towards Common Stockholders figures came in at -$7.6 million (Q2 2024), -$5.8 million (Q1 2024), and -$10.7 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 PRF Technologies 654,452.72 -3.49 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -7.60 Mn
Mar 31, 2024 -5.82 Mn
Dec 31, 2023 -10.74 Mn
Sep 30, 2023 -1.60 Mn
Jun 30, 2023 -2.50 Mn
Mar 31, 2023 -2.66 Mn
Dec 31, 2022 -8.88 Mn
Sep 30, 2022 -2.34 Mn
Jun 30, 2022 -2.08 Mn
Mar 31, 2022 -1.91 Mn
Dec 31, 2021 -6.89 Mn
Sep 30, 2021 -2.00 Mn
Jun 30, 2021 -1.88 Mn
Mar 31, 2021 -2.04 Mn
Dec 31, 2020 -4.17 Mn
Sep 30, 2020 -700,000.00
Jun 30, 2020 -969,000.00
Mar 31, 2020 -1.59 Mn